Eam Investors, LLC Sangamo Therapeutics, Inc Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$13.9 - $19.8 $3.05 Million - $4.34 Million	-219,415 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$16.7 - $26.35 $2.36 Million - $3.73 Million	141,416 Added 181.3%	219,415 $4.17 Million
Q4 2017 May 21, 2018	SELL	$11.6 - $17.35 $1.02 Million - $1.52 Million	-87,878 Reduced 52.98%	77,999 $1.28 Million
Q4 2017 Feb 12, 2018	SELL	$11.6 - $17.35 $546,940 - $818,052	-47,150 Reduced 22.13%	165,877 $2.72 Million
Q3 2017 Nov 08, 2017	BUY	$8.4 - $15.0 $1.79 Million - $3.2 Million	213,027	213,027 $3.2 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $191M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.